Barreras y facilitadores del sistema de salud relacionadas con el seguimiento de anormalidades citológicas, Medellín-Colombia
ABSTRACT: Identifying barriers and facilitators of the diagnostic monitoring and treatment of cytological abnormalities in low-income women users of the public health service network in Medellin, Colombia. Methods: We created eight focal groups (62 women) according to age groups (ages 25-45 and 46-6...
- Autores:
-
Garcés Palacio, Isabel Cristina
Rubio León, Diana Carolina
Ramos Jaraba, Sara Milena
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2014
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- spa
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/12083
- Acceso en línea:
- http://hdl.handle.net/10495/12083
- Palabra clave:
- Accesibilidad
Accessibility
Oportunidad
Opportunity
Seguimiento
Monitoring
Cáncer de cuello uterino
Cervical cancer
Barreras
Barriers
Anormalidades citológicas
Cytological abnormalities
- Rights
- openAccess
- License
- Atribución-NoComercial-SinDerivadas 2.5 Colombia
Summary: | ABSTRACT: Identifying barriers and facilitators of the diagnostic monitoring and treatment of cytological abnormalities in low-income women users of the public health service network in Medellin, Colombia. Methods: We created eight focal groups (62 women) according to age groups (ages 25-45 and 46-69), and performed a content analysis. Results: The reported barriers of the health system were: a) structural barriers: fragmentation in the provision of the service, problems with the affiliations and characteristics of the affiliation regime; b) management barriers: problems and delays in the assignment of appointments, long queues, problems with authorizations and mistreatment; and c) economic barriers derived from the aforementioned and related with expenses. Management and structural facilitators were also mentioned. Conclusion: Some structural characteristics of the health system and the management of insurance companies limit access for women to the monitoring of pre-cancerous lesions. |
---|